| 6201 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
66 |
| 6202 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
67 |
| 6203 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
38 |
| 6204 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
20 |
| 6205 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
47 |
| 6206 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
58 |
| 6207 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
31 |
| 6208 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
68 |
| 6209 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
60 |
| 6210 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
59 |
| 6211 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6212 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6213 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
58 |
| 6214 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
69 |
| 6215 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6216 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
60 |
| 6217 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6218 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
19 |
| 6219 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
68 |
| 6220 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6221 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6222 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia; Myeloproliferative Syndrome |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6223 |
Apheresis |
Autologous |
Amyloidosis |
Hematology |
2018 |
Standard Therapy |
Germany |
72 |
| 6224 |
Apheresis |
Autologous |
Amyloidosis |
Hematology |
2018 |
Standard Therapy |
Germany |
75 |
| 6225 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Germany |
61 |
| 6226 |
Apheresis |
Autologous |
Apoplexy |
Hematology |
2018 |
Standard Therapy |
Germany |
3 |
| 6227 |
Apheresis |
Allogeneic |
Atypical Chronic Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
58 |
| 6228 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
41 |
| 6229 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
50 |
| 6230 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
34 |
| 6231 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
34 |
| 6232 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
52 |
| 6233 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
46 |
| 6234 |
Apheresis |
Allogeneic |
B-Cell Chronic Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
65 |
| 6235 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
69 |
| 6236 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
43 |
| 6237 |
Apheresis |
Allogeneic |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6238 |
Apheresis |
Allogeneic |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
32 |
| 6239 |
Apheresis |
Allogeneic |
Blastic Nk Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
65 |
| 6240 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2018 |
Standard Therapy |
Poland |
15 |
| 6241 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6242 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
49 |
| 6243 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
38 |
| 6244 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
63 |
| 6245 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
48 |
| 6246 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
25 |
| 6247 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
41 |
| 6248 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
44 |
| 6249 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
54 |
| 6250 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
39 |
| 6251 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
63 |
| 6252 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
56 |
| 6253 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
71 |
| 6254 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
51 |
| 6255 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
67 |
| 6256 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
67 |
| 6257 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
49 |
| 6258 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
60 |
| 6259 |
Apheresis |
Allogeneic |
Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
54 |
| 6260 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
71 |
| 6261 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma – Relapse |
Hematology |
2018 |
Standard Therapy |
Germany |
71 |
| 6262 |
Apheresis |
Allogeneic |
Fanconi Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
9 |
| 6263 |
Apheresis |
Allogeneic |
Follicular Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
44 |
| 6264 |
Apheresis |
Autologous |
Follicular Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6265 |
Apheresis |
Allogeneic |
Follicular Lymphoma (Non-Hodgkin Lymphoma) |
Hematology |
2018 |
Standard Therapy |
Poland |
56 |
| 6266 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2018 |
Standard Therapy |
Germany |
23 |
| 6267 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2018 |
Standard Therapy |
Germany |
31 |
| 6268 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
38 |
| 6269 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
27 |
| 6270 |
Apheresis |
Allogeneic |
Hypoplastic Mds-Eb2 With Incipient Saml |
Hematology |
2018 |
Standard Therapy |
Poland |
63 |
| 6271 |
Apheresis |
Autologous |
Large B-Cell Non-Hodgkin-Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6272 |
Apheresis |
Allogeneic |
Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
34 |
| 6273 |
Apheresis |
Allogeneic |
Lymphomatoid Granulomatosis |
Hematology |
2018 |
Standard Therapy |
Germany |
36 |
| 6274 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6275 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
64 |
| 6276 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
44 |
| 6277 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6278 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6279 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2018 |
Standard Therapy |
Germany |
31 |
| 6280 |
Apheresis |
Allogeneic |
Morbus Hodgkin-Relapse |
Hematology |
2018 |
Standard Therapy |
Germany |
35 |
| 6281 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6282 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
61 |
| 6283 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
61 |
| 6284 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6285 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
57 |
| 6286 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
53 |
| 6287 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
57 |
| 6288 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6289 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
47 |
| 6290 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
60 |
| 6291 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
66 |
| 6292 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |
| 6293 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
67 |
| 6294 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
65 |
| 6295 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
54 |
| 6296 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
58 |
| 6297 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
51 |
| 6298 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
69 |
| 6299 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
52 |
| 6300 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2018 |
Standard Therapy |
Germany |
62 |